Suggested approaches for research protocols involving the potential for life-threatening reactions.
These guidelines are intended to reduce the potential for serious or life-threatening reactions when clinical research is conducted. The following issues were addressed: identifying the risks involved in the research, providing adequate safeguards in the protocol design and during withholding of medication, anticipating risks, minimizing the chances for human error, providing resuscitative equipment sufficient to deal with the most serious anticipated life-threatening reactions, planning for medical support in case of a life-threatening emergency, and optimizing the use of medical personnel and expertise to handle emergency situations. The guidelines also discuss important general issues about protocol design and implementation and the human subject consent form, which should facilitate the approval of protocols by the governing institutional review board. The guidelines are not meant to be inflexible or applicable to all research situations. However, it is our hope that they will allow for clinical research to be conducted in a manner that affords the research subjects a high degree of protection from unnecessary and possibly fatal injuries.
National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.
D L
DL
Hamilos
J J
JJ
Oppenheimer
H S
HS
Nelson
S
S
Wenzel
S
S
Driscoll
R F
RF
Lockey
D B
DB
Golden
L
L
Fan
R J
RJ
Sanks
S A
SA
Bock
D001980:Bronchi / Q000276:immunology; D002985:Clinical Protocols; D004311:Double-Blind Method; D005512:Food Hypersensitivity; D006801:Humans; D007167:Immunotherapy; D012107:Research Design